3,436 reports of this reaction
2.7% of all ATORVASTATIN CALCIUM, FILM COATED reports
#5 most reported adverse reaction
DYSPNOEA is the #5 most commonly reported adverse reaction for ATORVASTATIN CALCIUM, FILM COATED, manufactured by Accord Healthcare Inc.. There are 3,436 FDA adverse event reports linking ATORVASTATIN CALCIUM, FILM COATED to DYSPNOEA. This represents approximately 2.7% of all 126,371 adverse event reports for this drug.
Patients taking ATORVASTATIN CALCIUM, FILM COATED who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for ATORVASTATIN CALCIUM, FILM COATED, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for ATORVASTATIN CALCIUM, FILM COATED:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 3,436 FDA reports for ATORVASTATIN CALCIUM, FILM COATED. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 2.7% of all adverse event reports for ATORVASTATIN CALCIUM, FILM COATED, making it a notable side effect.
If you experience dyspnoea while taking ATORVASTATIN CALCIUM, FILM COATED, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.